Joint Webinar - 'De-risking Nasal & Pulmonary Formulation Development'

'De-risking Nasal & Pulmonary Formulation Development' - Joint Webinar hosted by ImmuONE

ImmuONE have joined forces with Nanopharm on this one to bring you leading experts driving innovation in pulmonary and nasal therapeutics, “De-risking Nasal & Pulmonary Formulation Development”.

When: Wednesday 26th November 2025 | 14:00 - 15:00 (UTC+00:00) Dublin, Edinburgh, Lisbon, London

This session will dive into how advanced in vitro models alongside analytical methods can support safer, more predictive formulation strategies, particularly for teams working in formulation development and drug discovery. It will be especially valuable for companies navigating the complexities of respiratory drug delivery.

What you’ll learn:

1. Insights into excipient selection and particle engineering for nasal and pulmonary formulations.

2. How toxicity and permeability impact formulation success

Register using this link: Microsoft Virtual Events Powered by Teams